Pharmaceutical Market

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of the type of biopharmaceutical products innovated and launched, evolving from management of chronic diseases in the 1990s to the expansive marketing of generic drugs, to now moving onto personalized therapies. To increase the suc...

Today, the most important factor affecting the world’s economy is the Global Pharmaceutical Industry. This industry is at the forefront driving about one trillion dollars annually. Pharmaceutical companies are driving a major share of the global economy with the rapidly advancing technological and scientific base, ...

The Pharmaceuticals segment of the Healthcare Industry has a significant market across the globe, which has grown quite extensively in the past few decades. The pharmaceutical sector has always been at the forefront of drug discovery, development, production, and marketing. The pharmaceutical industry in the twenty...

As part of its “Made in China 2025” industrial plan, China hopes to reinvent its pharmaceutical industry. President Xi Jinping has identified his country’s reliance on foreign drug imports as a critical concern. China’s enormous population, coupled with the rise of disease and illness, make the country a prime marke...

Vertex pharmaceutical’s growth story in biotech with Symdeko’s approval FDA has recently approved Vertex Pharmaceutical’s latest combination treatment, Symdeko, to serve the cystic fibrosis patient population. Symdeko's annual list price has been set at USD 292,000. Symdeko has paired with a fresh corrector, tezacaf...

With Flublok at a standstill in Japan, Astellas ditches collaborator UMN Pharma After Japanese regulators turned away the partners’ submission for a new cell-culture flu vaccine, Astellas has pulled the plug on a collaboration with UMN Pharma. UMN said it’s “regrettable” the companies can no longer work together to ...